Literature DB >> 8709403

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.

A G Bostom1, L A Cupples, J L Jenner, J M Ordovas, L J Seman, P W Wilson, E J Schaefer, W P Castelli.   

Abstract

OBJECTIVE: To establish whether elevated lipoprotein(a) [Lp(a)], detected as a sinking pre-beta-lipoprotein band on electrophoresis of fresh plasma, is an independent risk factor for the development of premature coronary heart disease (CHD) in men. DESIGN AND
SETTING: Prospective study of the Framingham offspring cohort. PARTICIPANTS: A total of 2191 men aged 20 to 54 years old who were free of cardiovascular disease when they were examined between 1971 and 1975. MAIN OUTCOME MEASURES: Incident CHD (myocardial infarction, coronary insufficiency, angina pectoris, or sudden cardiac death) occurring by age 55 years.
RESULTS: After a median follow-up of 15.4 years, there were 129 CHD events. The relative risk (RR) estimates (with 95% confidence intervals [CIs]) for premature CHD derived from a proportional hazards model that included age, body mass index, and the dichotomized risk factor covariables elevated plasma Lp(a) level, total cholesterol level of 6.2 mmol/L (240 mg/dL) or more, high-density lipoprotein (HDL) level less than 0.9 mmol/L (35 mg/dL), smoking, glucose intolerance, and hypertension were as follows: elevated Lp(a) level, RR, 1.9 (95% CI, 1.2-2.9), prevalence, 11.3%; total cholesterol level of 6.2 mmol/L or more, RR, 1.8 (95% CI, 1.2-2.7), prevalence, 14.3%; HDL level of less than 0.9 mmol/L, RR, 1.8 (95% CI, 1.2-2.6), prevalence 19.2%; smoking, RR 3.6 (95% CI, 2.2-5.5), prevalence, 46.7%; glucose intolerance, RR, 2.7 (95% CI, 1.4-5.3), prevalence, 2.6%; hypertension, RR, 1.2 (95% CI, 0.8-1.8), prevalence, 26.3%.
CONCLUSIONS: Elevated plasma Lp(a) is an independent risk factor for the development of premature CHD in men, comparable in magnitude and prevalence (ie, attributable risk) to a total cholesterol level of 6.2 mmol/L (240 mg/dL) or more, or an HDL level less than 0.9 mmol/L (35 mg/dL).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709403     DOI: 10.1001/jama.1996.03540070040028

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  50 in total

1.  Evaluation of Hypercoagulable States.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

3.  Convergent evolution of apolipoprotein(a) in primates and hedgehog.

Authors:  R M Lawn; K Schwartz; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 4.  Novel serologic markers of cardiovascular risk.

Authors:  Guilherme H M Oliveira
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

5.  Genetics of coronary artery disease: focus on genome-wide association studies.

Authors:  Linnea M Baudhuin
Journal:  Am J Transl Res       Date:  2009-03-05       Impact factor: 4.060

Review 6.  [Coronary heart disease as inflammatory disease of the vascular bed? Etiology, sequela or misconception?].

Authors:  B Maisch
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

7.  Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study.

Authors:  M Paassilta; K Kervinen; A O Rantala; M J Savolainen; M Lilja; A Reunanen; Y A Kesäniemi
Journal:  BMJ       Date:  1998-02-21

8.  Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.

Authors:  Beate R Jaeger; Yvonne Richter; Dorothea Nagel; Franz Heigl; Anja Vogt; Eberhard Roeseler; Klaus Parhofer; Wolfgang Ramlow; Michael Koch; Gerd Utermann; Carlos A Labarrere; Dietrich Seidel
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 9.  The role of non-LDL:non-HDL particles in atherosclerosis.

Authors:  Jere P Segrest
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

10.  Age-related effects of regular physical activity on hemostatic factors in men.

Authors:  Jun Sugawara; Koichiro Hayashi; Sumiko Kurachi; Taku Tanaka; Takashi Yokoi; Kotoku Kurachi
Journal:  J Thromb Thrombolysis       Date:  2007-09-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.